Search
Phenyltoloxamine H1-Antihistamine Action
smpdb.ca/view/SMP0058916Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaBuclizine H1-Antihistamine Action
smpdb.ca/view/SMP0058964Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaMequitazine H1-Antihistamine Action
smpdb.ca/view/SMP0059720Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaAzatadine H1-Antihistamine Action
smpdb.ca/view/SMP0059865Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaAstemizole H1-Antihistamine Action
smpdb.ca/view/SMP0059897Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaEbastine H1-Antihistamine Action
smpdb.ca/view/SMP0060204Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaTerfenadine H1-Antihistamine Action
smpdb.ca/view/SMP0060208Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaRupatadine H1-Antihistamine Action
smpdb.ca/view/SMP0060235Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaEmedastine H1-Antihistamine Action
smpdb.ca/view/SMP0061040Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alphaTolpropamine H1-Antihistamine Action
smpdb.ca/view/SMP0062621Drug actionReducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression
Enzymes: Protein kinase C beta type, Guanine nucleotide-binding protein G(q) subunit alpha